A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection

Alexsandra Lenhard1, Basma H Joma2, Nalat Siwapornchai3

  • 1Department of Microbiology and Immunology, University at Buffalo School of Medicine.

Insights

A new mouse model shows how influenza A virus infection enables asymptomatic Streptococcus pneumoniae to cause severe pneumonia, especially in older mice. This model aids in studying disease progression and finding new treatments.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogen-Host Interactions

Background:

  • Streptococcus pneumoniae (pneumococcus) typically colonizes the nasopharynx asymptomatically.
  • Influenza A virus (IAV) infection can trigger pneumococcal transition to a severe pulmonary and systemic pathogen.
  • Advanced age increases susceptibility and worsens outcomes of secondary pneumococcal pneumonia.

Purpose of the Study:

  • To develop and characterize a novel mouse model that recapitulates the transition of pneumococci from asymptomatic carriage to severe disease following IAV infection.
  • To investigate age-dependent susceptibility to secondary pneumococcal pneumonia.

Main Methods:

  • Establishment of asymptomatic pneumococcal carriage via intranasal inoculation of biofilm-grown bacteria.
  • Induction of IAV infection in the nasopharynx and lungs to trigger bacterial dissemination and disease.
  • Evaluation of disease severity, progression, and lethality in young and aged mice.

Main Results:

  • The model successfully recreates pneumococcal transition from carriage to severe pneumonia and systemic disease upon IAV co-infection.
  • Disease severity is influenced by bacterial strain and host factors.
  • Aged mice exhibit significantly increased susceptibility, more severe clinical illness, and higher mortality rates compared to young mice.

Conclusions:

  • This S. pneumoniae/IAV co-infection mouse model effectively mimics secondary pneumococcal pneumonia, including age-related susceptibility.
  • The model allows for detailed analysis of pathogen-host interactions during different disease phases.
  • It serves as a valuable tool for identifying therapeutic targets against secondary pneumococcal pneumonia in susceptible populations, particularly the elderly.